Resurfacing Lenskart's November move: eyewear lead widens with 203 new stores and 19.8% EBITDA margin
Revisiting Lenskart's early-November India expansion, local frame production and digital eye-testing model that lifted growth and profitability, while Titan EyeCare reported income growth but a sharp EBIT decline. The contrast underscores two competing bets: Lenskart's scale-led convenience versus Titan's clinical-service positioning.
What happened
Lenskart is scaling India eyewear through AI-led site selection, remote eye tests, local manufacturing and fast delivery, delivering stronger margins than Titan
Key facts
- Lenskart listed at Rs 390 versus Rs 402 issue price
- Lenskart added 203 net new India stores in H1 FY26 and reached 431 cities
- Titan EyeCare had 871 exclusive stores as of September 2025
- Lenskart conducted 9.3 million eye tests in India in H1 FY26; 46% were first-time users
- Lenskart Q2 FY26 revenue rose 24% YoY to Rs 2,146.6 crore
- Lenskart Q2 FY26 EBITDA was Rs 425.8 crore, with a 19.8% margin
- Lenskart H1 FY26 EBITDA margin rose to 19.5% from 17.3%
- Titan EyeCare domestic total income rose to Rs 215 crore from Rs 199 crore
- Titan EyeCare EBIT fell to Rs 12 crore from Rs 24 crore
- Lenskart local frame production offers a stated 35%-40% cost advantage
Why this matters
The divergence makes eye-care technology, local frame manufacturing and high-quality regional optical chains attractive partnership or acquisition targets for players seeking to match Lenskart’s integrated scale.
What to watch
- Lenskart same-store sales growth, new-store payback periods and whether EBITDA margin remains near 20% as expansion continues.
- Titan EyeCare EBIT margin, store productivity, prescription conversion and evidence of reduced discounting or fixed-cost rationalization.
- Changes in eyewear pricing, promotional intensity and online-to-store conversion rates across major Indian cities.
- Capacity additions and utilization at Lenskart's domestic manufacturing operations.
- Any regulatory or consumer-health scrutiny around digital eye testing and prescription quality.
- Lenskart is likely to prioritize cluster expansion in tier-2 and tier-3 cities, using dense store networks to shorten delivery times and increase eye-test conversion.
- Expect further investment in domestic frame and lens production to defend gross margin, reduce import exposure and support faster assortment refreshes.
- Titan EyeCare may shift capital toward higher-yield stores, premium formats, service-led differentiation and tighter cost control rather than matching Lenskart store-for-store.
- Independent optical retailers may seek franchise alliances, local digital eye-testing partnerships or exclusive premium-brand assortments to remain differentiated.